Athos Capital Ltd acquired a new position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) during the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 40,000 shares of the biopharmaceutical company’s stock, valued at approximately $4,552,000. Horizon Therapeutics Public comprises about 2.6% of Athos Capital Ltd’s holdings, making the stock its […]
StockNews.com initiated coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Get Rating) in a research report released on Sunday. The firm issued a buy rating on the biopharmaceutical company’s stock. Separately, TheStreet lowered shares of Horizon Therapeutics Public from a b- rating to a c+ rating in a research report on Monday, May 8th. […]
StockNews.com assumed coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Get Rating) in a report published on Sunday. The firm issued a buy rating on the biopharmaceutical company’s stock. Separately, TheStreet downgraded Horizon Therapeutics Public from a b- rating to a c+ rating in a research note on Monday, May 8th. Eight research analysts […]
Mirae Asset Global Investments Co. Ltd. trimmed its position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 43.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 45,913 shares of the biopharmaceutical company’s stock after selling […]
Intrust Bank NA lifted its position in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 9.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 16,176 shares of the biopharmaceutical company’s stock after buying an additional 1,354 shares during the […]